AU2002213195A1 - Reduction or prevention of post-surgical adhesion formation with fibrinogen - Google Patents

Reduction or prevention of post-surgical adhesion formation with fibrinogen

Info

Publication number
AU2002213195A1
AU2002213195A1 AU2002213195A AU1319502A AU2002213195A1 AU 2002213195 A1 AU2002213195 A1 AU 2002213195A1 AU 2002213195 A AU2002213195 A AU 2002213195A AU 1319502 A AU1319502 A AU 1319502A AU 2002213195 A1 AU2002213195 A1 AU 2002213195A1
Authority
AU
Australia
Prior art keywords
fibrinogen
prevention
post
reduction
adhesion formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213195A
Inventor
Heinz Redl
Manuela Simunek
Reiner Spaethe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of AU2002213195A1 publication Critical patent/AU2002213195A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
AU2002213195A 2000-10-13 2001-10-12 Reduction or prevention of post-surgical adhesion formation with fibrinogen Abandoned AU2002213195A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24020000P 2000-10-13 2000-10-13
US60/240,200 2000-10-13
PCT/US2001/032044 WO2002030446A2 (en) 2000-10-13 2001-10-12 Reduction or prevention of post-surgical adhesion formation with fibrinogen

Publications (1)

Publication Number Publication Date
AU2002213195A1 true AU2002213195A1 (en) 2002-04-22

Family

ID=22905541

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213195A Abandoned AU2002213195A1 (en) 2000-10-13 2001-10-12 Reduction or prevention of post-surgical adhesion formation with fibrinogen

Country Status (2)

Country Link
AU (1) AU2002213195A1 (en)
WO (1) WO2002030446A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257438B2 (en) 2005-04-12 2012-09-04 Warsaw Orthopedic, Inc. Methods and devices for preserving motion in an articulating prosthetic disc
EP2011524A1 (en) * 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrin glue with a visualization agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9101853D0 (en) * 1991-06-17 1991-06-17 Jonas Wadstroem IMPROVED TISSUE ASHESIVE
ATE234642T1 (en) * 1998-05-01 2003-04-15 Zymogenetics Inc FULLY RECOMBINANT TISSUE ADHESIVE
DE10025001A1 (en) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Tissue glue with improved anti-adhesive properties
AT500670A1 (en) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa DRUGS FOR LOCAL APPLICATION
NZ515585A (en) * 1999-06-01 2004-06-25 Bristol Myers Squibb Co Prevention of post surgical adhesions using a fibrin monomer sealant

Also Published As

Publication number Publication date
WO2002030446A3 (en) 2003-07-24
WO2002030446A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2002360983A1 (en) Adhesion inhibition of fungi
AU2002218182A1 (en) Adhesives having barrier properties
AU2001241893A1 (en) Barrier coating
AU7373700A (en) Vascular closure
AU2001240978A1 (en) Glycogen phosphorylase inhibitor
AU2940800A (en) Refrigerator
EP1096040A3 (en) Chromate-free phosphate bonding composition
AU1530001A (en) Inhibitor compositions
AU1488501A (en) Methods of inhibiting metastasis
AU2001268701A1 (en) Methods of enhancing adhesion
AUPQ629000A0 (en) Inhibition of fungi
AU2002213194A1 (en) Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
AU4369000A (en) Inhibition of complement action
AU2002213195A1 (en) Reduction or prevention of post-surgical adhesion formation with fibrinogen
AU2002239459A1 (en) Persistent modem connection
AU6517800A (en) Ntr3, a member of the tnf-receptor supergene family
AU6769900A (en) Formation of nanometer-scale structures
AU7887100A (en) Corrosion inhibitor
AU2001276148A1 (en) Door fastening
AU2002231312A1 (en) Bond enhancement antitarnish coatings
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU2001281123A1 (en) Haplotypes of the isl1 gene
AUPQ190199A0 (en) Building
AU2000226055A1 (en) Built-up i-beam with laminated flange
AUPQ167599A0 (en) Inhibitor of osteoclast precursor formation